KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Opko Health (OPK) EBIT Margin (2016 - 2025)

Opko Health's EBIT Margin history spans 16 years, with the latest figure at 25.81% for Q4 2025.

  • For Q4 2025, EBIT Margin changed N/A year-over-year to 25.81%; the TTM value through Dec 2025 reached 19.35%, changed N/A, while the annual FY2025 figure was 19.35%, 198.0% up from the prior year.
  • EBIT Margin reached 25.81% in Q4 2025 per OPK's latest filing, down from 31.68% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 3782.6% in Q3 2021 to a low of 1223.76% in Q1 2023.
  • Average EBIT Margin over 5 years is 120.14%, with a median of 25.81% recorded in 2025.
  • Peak YoY movement for EBIT Margin: surged 377747bps in 2021, then tumbled -383146bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 15.72% in 2021, then plummeted by -90bps to 29.82% in 2022, then dropped by -27bps to 37.96% in 2023, then surged by 255bps to 58.99% in 2024, then crashed by -144bps to 25.81% in 2025.
  • Per Business Quant, the three most recent readings for OPK's EBIT Margin are 25.81% (Q4 2025), 31.68% (Q3 2025), and 38.25% (Q2 2025).